We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

76 hedge funds and large institutions have $11.8M invested in Precision BioSciences in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

0.28% less ownership

Funds ownership: 1.28% → 1% (-0.28%)

1% less funds holding

Funds holding: 77 → 76 (-1)

49% less capital invested

Capital invested by funds: $23M → $11.8M (-$11.2M)

Holders
76
Holders Change
-1
Holders Change %
-1.3%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
19
Reduced
16
Closed
12
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$330K
2
Bank of America
Bank of America
North Carolina
+$327K
3
Citadel Advisors
Citadel Advisors
Florida
+$216K
4
MSAM
Moloney Securities Asset Management
Missouri
+$169K
5
Goldman Sachs
Goldman Sachs
New York
+$158K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$3.93M
2
JP Morgan Chase
JP Morgan Chase
New York
-$857K
3
CA
CHI Advisors
New York
-$511K
4
GCP
GSA Capital Partners
United Kingdom
-$247K
5
Stifel Financial
Stifel Financial
Missouri
-$223K
Name Holding Trade Value Shares
Change 		Change in
Stake
PTP
51
Platform Technology Partners
New York
$9.21K – – –
PFO
52
Pathstone Family Office
New Jersey
$9.03K +$13.6K +882 New
VF
53
Virtu Financial
New York
$9K +$14K +911 New
Bank of New York Mellon
54
Bank of New York Mellon
New York
$8.66K – – –
N
55
Natixis
France
$8.29K +$108 +7 +0.9%
Cambridge Investment Research Advisors
56
Cambridge Investment Research Advisors
Iowa
$5K – – –
GW
57
GW & Wade
Massachusetts
$5K – – –
HSA
58
HBK Sorce Advisory
Pennsylvania
$4.61K +$6.92K +450 New
6F
59
626 Financial
Michigan
$4.5K – – –
TSS
60
Two Sigma Securities
New York
$4.02K +$6.02K +392 New
Zurich Cantonal Bank
61
Zurich Cantonal Bank
Switzerland
$4.01K -$476 -31 -7%
TYCC
62
Texas Yale Capital Corp
Florida
$3.41K – – –
Wells Fargo
63
Wells Fargo
California
$2.62K – – –
TFGT
64
TS Financial Group (TSFG)
Illinois
$1K – – –
SC
65
SouthState Corp
Florida
$973 – – –
AWM
66
Ameliora Wealth Management
Switzerland
$341 – – –
FDCDDQ
67
Federation des caisses Desjardins du Quebec
Quebec, Canada
$155 +$46 +3 +25%
Qube Research & Technologies (QRT)
68
Qube Research & Technologies (QRT)
United Kingdom
$87 +$138 +9 New
IRC
69
Investors Research Corp
Georgia
$85 -$61 -4 -33%
NA
70
NewEdge Advisors
Louisiana
$56 – – –
BHWM
71
Beaird Harris Wealth Management
Texas
$46 – – –
AWA
72
Authentikos Wealth Advisory
California
$43 +$61 +4 New
National Bank of Canada
73
National Bank of Canada
Quebec, Canada
$33 +$46 +3 New
Group One Trading
74
Group One Trading
Illinois
$1 – – –
GPP
75
Great Point Partners
Connecticut
– -$3.93M -248,991 Closed
1 2
3
4

DTIL Hedge Fund Activity: Q3 2023 in Review

76 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2023, worth a combined $11.8M — down 49% from $23M a quarter earlier.

Fund positioning in DTIL was balanced in Q3 2023: 12 funds opened new positions, 12 closed out, 19 added to existing stakes and 16 trimmed.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $330K. The largest seller was Great Point Partners, exiting entirely with an estimated $3.93M sold.

  • 76 institutional investors held Precision BioSciences (DTIL) as of Q3 2023, down from 77 in Q2 2023.
  • Funds reported $11.8M of Precision BioSciences stock for Q3 2023, down 49% quarter-over-quarter.
  • 12 funds opened new Precision BioSciences positions in Q3 2023 and 12 closed out, a net change of 0 holders.
  • The largest Precision BioSciences buyer in Q3 2023 was Jacobs Levy Equity Management, an estimated $330K added.
  • The largest Precision BioSciences seller in Q3 2023 was Great Point Partners, an estimated $3.93M sold.

Based on aggregated 13F filings for Q3 2023.